Chemistry, asked by 0neAboveAll, 7 hours ago

Which of the following chemotherapy agents is approved by FDA for use in radioiodine refractory papillary thyroid cancer :

a) Doxorubicin
b) Paclitaxel
c) Vincristine
d) Gemcitabine

Answers

Answered by OoINTROVERToO
0

Question

Which of the following chemotherapy agents is approved by FDA for use in radioiodine refractory papillary thyroid cancer :

  • Doxorubicin
  • Paclitaxel
  • Vincristine
  • Gemcitabine

Answer

  • DOXORUBICIN

\\

Answered by dakshkoche62
1

Answer:

Sorafenib is the first targeted systemic agent to demonstrate benefit in RAI-refractory thyroid cancer and was recently approved for the treatment of locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to RAI treatment [US Food and Drug Administration, 2013].

Similar questions